# OnCo record aptamer-sciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aptamer-sciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aptamer-sciences" ;
  schema:name "Aptamer Sciences"@en ;
  schema:alternateName "Choolip & Science"@en, "CHOOLIP & SCIENCE Inc"@en ;
  schema:description "Aptamer Sciences builds medicines from aptamers, short strands of DNA that fold into shapes able to grip a protein on cancer cells, and uses them to carry chemotherapy into tumours. Its lead medicine, AST-201, targets liver and lung cancers that carry the GPC3 protein and is in a first human trial; it also sells a blood test to help assess lung nodules."@en ;
  schema:url <https://onco.cc/companies/aptamer-sciences/>, <https://www.aptsci.com/en/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.aptsci.com/en/>, <https://www.aptsci.com/en/company/history.php>, <https://clinicaltrials.gov/study/NCT06687941>, <https://www.aptsci.com/en/pr/news.php?bgu=view&idx=291> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> ;
  onco:targets <https://onco.cc/targets/gpc3/> .